ZEVTERA Trademark

Trademark Overview

On Tuesday, July 27, 2021, a trademark application was filed for ZEVTERA with the United States Patent and Trademark Office. The USPTO has given the ZEVTERA trademark a serial number of 90849714. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 13, 2024. This trademark is owned by Basilea Pharmaceutica International Ltd.. The ZEVTERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, neurological diseases, cardiovascular diseases, gynecological diseases, and autoimmune diseases
zevtera

General Information

Serial Number90849714
Word MarkZEVTERA
Filing DateTuesday, July 27, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, neurological diseases, cardiovascular diseases, gynecological diseases, and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4058
CH

Trademark Events

Event DateEvent Description
Friday, July 30, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 22, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 14, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, September 14, 2022NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 20, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 2 FILED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 3 FILED
Wednesday, August 14, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 1 FILED
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 2 GRANTED

Related Keywords

zevtera diseases gastrointestinal neurological cardiovascular autoimmune gynecological oncological dermatological substances preparations